Gregory J Riggins

USPTO Granted Patents = 19 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 4)

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 139(Granted Patents)

Location History:

Durham, NC (US) (2006)
Baltimore, MD (US) (2008 - 2023)
White Hall, MD (US) (2014 - 2023)

Company Filing History:

15 out of 3,687

Johns Hopkins University

University of Illinois

patents

4. 5 out of 10

Vanquish Oncology, Inc.

patents

5. 1 out of 14

Institute of Organic Chemistry and Biochemistry Ascr, V.v.i.

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433885 - Procaspase combination therapy for glioblastoma (2025-10-07),

2. 11844798 - Procaspase combination therapy for glioblastoma (2023-12-19),

3. 11712435 - Mebendazole prodrugs with enhanced solubility and oral bioavailability (2023-08-01),

4. 11628204 - Preventing cytokine release syndrome (2023-04-18),

5. 11110079 - Mebendazole polymorph for treatment and prevention of tumors (2021-09-07),

6. 10894987 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2021-01-19),

7. 10874666 - Procaspase combination therapy for glioblastoma (2020-12-29),

8. 10837064 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2020-11-17),

9. 10704108 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2020-07-07),

10. 10085978 - Procaspase combination therapy for glioblastoma (2018-10-02),

11. 9695479 - Medulloblastoma genes as targets for diagnosis and therapeutics (2017-07-04),

12. 9421202 - Procaspase combination therapy for glioblastoma (2016-08-23),

13. 9353418 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2016-05-31),

14. 8685660 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2014-04-01),

15. 8394580 - Protein markers for the detection of thyroid cancer metastasis (2013-03-12),

Title: Gregory J Riggins: Pioneering Inventor from Baltimore

Introduction: Gregory J Riggins is a distinguished inventor hailing from Baltimore, Maryland, known for his groundbreaking contributions to the field of innovation.

Latest Patents: Gregory J Riggins holds several patents in the medical technology sector, focusing on advancements in cancer treatment and diagnostic tools.

Career Highlights: With a career spanning over two decades, Riggins has worked tirelessly to develop cutting-edge solutions that have revolutionized the medical industry.

Collaborations: Throughout his career, Gregory J Riggins has collaborated with leading research institutions, universities, and medical companies to bring his inventions to life and make a significant impact on patient care.

Conclusion: Gregory J Riggins' passion for innovation and commitment to improving healthcare have solidified his reputation as a visionary inventor in Baltimore and beyond.

This text is generated by artificial intelligence and may not be accurate.